Sclavo Diagnostics Intl. Srl Italy

Achille Sclavo develops the serum against anthrax in 1904 and founds the Istituto Sieroterapico e Vaccinogeno Toscano. In 1929, the Sclavo Institute begins producing the anatoxin against diphtheria and tetanus and later, the smallpox vaccine. In 1934, the first diagnostic products are developed and in 1977, the U.S. Food and Drug Administration grants the registration of these products. In 1992, Sclavo Diagnostics International commences business, and in 2003 the plant is moved to the new, technologically avant-garde site in Sovicille (province of Siena). On June 1, 2004, Sclavo becomes a partner in the D-Group.